Business
Sernova's Collaborator to Present Cell Pouch(TM) Thyroid Transplant Study Results at the American Association of Endocrine Surgeons 2021 Annual Meeting
(TheNewswire) LONDON, ONTARIO – TheNewswire - Fe...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova's Collaborator to Present Cell Pouch(TM) Thyroid Transplant Study Results at the American Association of Endocrine Surgeons 2021 Annual Meeting\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n LONDON, ONTARIO –\n \n TheNewswire -\n \n February 3, 202\n \n 1\n \n – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a leading\nclinical-stage regenerative medicine therapeutics company, is pleased\nto announce that Dr. Sam Wiseman, BSc, MD, FRCSC, FACS of the\nUniversity of British Columbia and co-investigator of Sernova’s Cell\nPouch Hypothyroid treatment program will present preclinical data in\nan oral presentation at the American Association of Endocrine Surgeons\n(AAES) 2021 Annual Meeting taking place April 25-27, 2021. Dr. Sam\nWiseman,\n \n Professor, Richard J. Finley Scholar, and\nDirector of Research at the Department of Surgery of Providence Health\nCare also serves as Chair of the Endocrine Tumor Group for the\nSurgical Oncology Network in Vancouver British Columbia.\n \n \n \n Dr. Wiseman’s abstract was selected amongst over 140 abstracts for\nan Oral Podium Presentation and a resulting journal article will be\npeer-reviewed for publication consideration in the journal\n \n Surgery.\n \n \n \n For more information on the American Association of Endocrine Surgeons\nand the 41\n \n st\n \n Annual\nMeeting, visit\n \n \n https://meeting.endocrinesurgery.org/\n \n \n .\n \n \n \n ABOUT SERNOVA’S HYPOTHYROID PROGRAM\n \n \n \n Sernova’s initial approach in treating hypothyroid disease is to\ntransplant a patient’s own healthy thyroid tissue following\nthyroidectomy into the pre-implanted vascularized Cell Pouch to\nrecover the normal function of the thyroid gland. In collaboration\nwith Dr. Wiseman, preclinical proof of concept work is being conducted\nunder a grant from the British Columbia Transplant Foundation.\nFollowing successful completion of preclinical studies, Sernova plans\nto conduct clinical assessments of the Cell Pouch with transplanted\nthyroid tissue in patients suffering from hypothyroid disease with the\naim to preserve thyroid function and improve patient quality of life.\n \n \n Thyroidectomy is commonly performed for cancer diagnosis or treatment\nand for treatment of benign (non-cancerous) disease that includes...